印度古吉拉特邦一名接种疫苗后的医护人员感染感兴趣的新冠病毒卡帕变种（B.1.617.1）后病情减轻 - Suppr

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.

作者信息

Sahay Rima Rakeshkumar, Shete Anita M, Sapkal Gajanan N, Deshpande Gururaj R, Shah Arti D, Kumar Sanjay, Abraham Priya, Yadav Pragya D

机构信息

Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India.

Diagnostic Virology Group, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India.

出版信息

Indian J Med Res. 2022 May-Jun;155(5&6):575-577. doi: 10.4103/ijmr.ijmr_1390_21.

DOI:10.4103/ijmr.ijmr_1390_21

PMID:35975349

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9807192/

Abstract

摘要

相似文献

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.

Indian J Med Res. 2022 May-Jun;155(5&6):575-577. doi: 10.4103/ijmr.ijmr_1390_21.

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.

J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.016. Epub 2021 Jun 18.

[Vaccination of healthcare workers against COVID-19].

Soins. 2021 May;66(855):10-13. doi: 10.1016/S0038-0814(21)00120-1.

Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.

J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.027. Epub 2021 Apr 29.

No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.

Sci Rep. 2021 Dec 17;11(1):24198. doi: 10.1038/s41598-021-03685-y.

Transition of Antibody Titers after SARS-CoV-2 mRNA Vaccination in Japanese Healthcare Workers.

Jpn J Infect Dis. 2023 Jan 24;76(1):72-76. doi: 10.7883/yoken.JJID.2022.041. Epub 2022 Aug 31.

Relative Effectiveness of COVID-19 Vaccination in Healthcare Workers: 3-Dose Versus 2-Dose Vaccination.

J Korean Med Sci. 2022 Sep 5;37(35):e267. doi: 10.3346/jkms.2022.37.e267.

Post-vaccination SARS-CoV-2 infection among healthcare workers in tertiary care hospitals in Saudi Arabia: A case series.

J Infect Public Health. 2022 Jan;15(1):10-12. doi: 10.1016/j.jiph.2021.11.015. Epub 2021 Nov 19.

Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.

BMJ Open. 2022 Jun 28;12(6):e054336. doi: 10.1136/bmjopen-2021-054336.

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers.

J Biol Rhythms. 2022 Feb;37(1):124-129. doi: 10.1177/07487304211059315. Epub 2021 Dec 4.

本文引用的文献

Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.

Viruses. 2021 Sep 7;13(9):1782. doi: 10.3390/v13091782.

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.

Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.

Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals.

J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab119.

Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees.

Clin Infect Dis. 2022 Jan 29;74(2):366-368. doi: 10.1093/cid/ciab411.

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.

N Engl J Med. 2021 May 6;384(18):1774-1775. doi: 10.1056/NEJMc2101927. Epub 2021 Mar 23.

Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India.

Travel Med Infect Dis. 2021 May-Jun;41:102023. doi: 10.1016/j.tmaid.2021.102023. Epub 2021 Mar 14.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.

Lancet Infect Dis. 2021 Jul;21(7):950-961. doi: 10.1016/S1473-3099(21)00070-0. Epub 2021 Mar 8.

Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage.

J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taab009.

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.

Indian J Med Res. 2020 May;151(5):444-449. doi: 10.4103/ijmr.IJMR_2232_20.

Development of transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India.

Indian J Med Res. 2020;151(2 & 3):251-254. doi: 10.4103/ijmr.IJMR_671_20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献